Helix Acquisition Corp. III Prices IPO at $10.00 per Share
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 13h ago
0mins
Helix Acquisition Corp. III priced its upsized initial public offering of 15M Class A ordinary shares at $10.00 per share. The shares are listed on The Nasdaq Global Market and trade under the ticker symbol "HLXC" beginning today. The special purpose acquisition company may pursue an initial business combination target in any business or industry, but intends to focus on opportunities in healthcare or healthcare-related industries. Leerink Partners and Oppenheimer are serving as the joint bookrunning managers for the offering.
Analyst Views on HLXC
Wall Street analysts forecast HLXC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HLXC is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 10.000
Low
Averages
High
Current: 10.000
Low
Averages
High
No data
About HLXC
Helix Acquisition Corp III located in Boston, Massachusetts is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
